Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

From L-R, Garcia, Wahl and Battaglia Approximately 15 million to 20 million Americans who have acquired COVID-19 experience ...

New evidence suggests that SARS-CoV-2 infection can lead to the rapid development of achalasia, a rare esophageal motility disorder. The etiology of achalasia is unclear. Studies have suggested an ...

New research reveals promising drug targets to block coronaviruses at multiple stages of infection—even across different ...

In a recent review published in the journal Cell Communication and Signaling, a team of researchers in Egypt and the United States explored the direct and indirect mechanisms of T lymphocyte-linked ...

In maintenance hemodialysis (MHD) patients infected with SARS-CoV-2, various thromboembolic complications have been reported, ...

Despite vaccines and treatments, SARS-CoV-2-the virus that causes COVID-19-continues to pose a global health threat, driven ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Nearly 85% of people with long COVID had experienced ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

It is well-established that COVID-19 is a systemic disease. Besides the respiratory system, the virus can infect different ...